🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to characterize safety of JNJ-68284528 and esta...
Status
Completed
Location
Mayo Clinic Cancer Center-Scottsdale
Start Date
2018-06-29
Trial ID
NCT03548207
Treatments Being Tested
The goal of this clinical trial is to study the feasibility and efficacy of...
Status
Unknown
Location
Shanghai Changzheng Hospital
Start Date
2019-07-08
Trial ID
NCT03943472
Treatments Being Tested
This is an investigator-initiated, single-center, open-label study of C-CAR...
Status
Not Yet Recruiting
Location
The Affiliated Hospital of Qingdao University
Start Date
2026-07
Trial ID
NCT07676266
Treatments Being Tested
This phase I trial determines the side effects and best dose of B-cell matu...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2018-05-23
Trial ID
NCT03502577
This is a multicenter, open-label, dose-escalation/expansion phase 1/2a stu...
Status
Unknown
Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
Start Date
2024-01-11
Trial ID
NCT06223646
Treatments Being Tested
This is a single-center, open clinical study, divided into two phases of do...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-25
Trial ID
NCT06655519
Treatments Being Tested
This phase I trial studies the side effects and best dose of BCMA CAR-T cel...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2017-11-29
Trial ID
NCT03338972
A Phase 1 study of HBI0101 BCMA-CART in B-Cell Mediated Autoimmune Rheumati...
Status
Recruiting
Location
Hadassah MO
Start Date
2024-09-01
Trial ID
NCT07085676
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of LCAR-B3...
Status
Terminated
Location
Peking University Third Hospital
Start Date
2019-01-23
Trial ID
NCT03758417
Treatments Being Tested
This Phase I study will test the safety and anti-myeloma activity of ascend...
Status
Terminated
Location
The Center for Cancer and Blood Disorders
Start Date
2018-03-08
Trial ID
NCT03448978
Treatments Being Tested